Founder p.Arg 446 mutation in the PDHX gene explains over half of cases with congenital lactic acidosis in Roma children

• Published in: Molecular genetics and metabolism 2014-09, Vol.113 (1-2), p.76-83
• Main Authors: Ivanov, Ivan S., Azmanov, Dimitar N., Ivanova, Mariya B., Chamova, Teodora, Pacheva, Ilyana H., Panova, Margarita V., Song, Sharon, Morar, Bharti, Yordanova, Ralitsa V., Galabova, Fani K., Sotkova, Iglika G., Linev, Alexandar J., Bitchev, Stoyan, Shearwood, Anne-Marie J., Kancheva, Dalia, Gabrikova, Dana, Karcagi, Veronika, Guergueltcheva, Velina, Geneva, Ina E., Bozhinova, Veneta, Stoyanova, Vili K., Kremensky, Ivo, Jordanova, Albena, Savov, Aleksey, Horvath, Rita, Brown, Matthew A., Tournev, Ivailo, Filipovska, Aleksandra, Kalaydjieva, Luba
• Format: Article
• Language: English
• Subjects: Acidosis, Lactic - diagnosis; Acidosis, Lactic - genetics; Adolescent; Child; Child, Preschool; Codon; Congenital lactic acidosis; Consanguinity; DNA Mutational Analysis; Female; Founder Effect; Genotype; Humans; Infant; Infant, Newborn; Male; Mutation; PDHX; Phenotype; Pyruvate Dehydrogenase Complex - genetics; Roma/Gypsy founder mutation; Romania; Slovakia
• ISSN: 1096-7192; 1096-7206
• DOI: 10.1016/j.ymgme.2014.07.017

Investigation of 31 of Roma patients with congenital lactic acidosis (CLA) from Bulgaria identified homozygosity for the R446* mutation in the PDHX gene as the most common cause of the disorder in this ethnic group. It accounted for around 60% of patients in the study and over 25% of all CLA cases referred to the National Genetic Laboratory in Bulgaria. The detection of a homozygous patient from Hungary and carriers among population controls from Romania and Slovakia suggests a wide spread of the mutation in the European Roma population. The clinical phenotype of the twenty R446* homozygotes was relatively homogeneous, with lactic acidosis crisis in the first days or months of life as the most common initial presentation (15/20 patients) and delayed psychomotor development and/or seizures in infancy as the leading manifestations in a smaller group (5/20 patients). The subsequent clinical picture was dominated by impaired physical growth and a very consistent pattern of static cerebral palsy-like encephalopathy with spasticity and severe to profound mental retardation seen in over 80% of cases. Most patients had a positive family history. We propose testing for the R446* mutation in PDHX as a rapid first screening in Roma infants with metabolic acidosis. It will facilitate and accelerate diagnosis in a large proportion of cases, allow early rehabilitation to alleviate the chronic clinical course, and prevent further affected births in high-risk families. •We investigate the causes of congenital lactic acidosis in affected Roma children.•A single ancestral mutation, R446* in PDHX, accounts for over 60% of cases.•Lactic acidosis crisis in early infancy is the predominant initial presentation.•Non-progressive cerebral palsy-like encephalopathy is the outcome in 80% of patients.•R446* testing in Roma infants with metabolic acidosis can speed up the diagnosis.